dot.LA Dives In: Frame Co-founders Discuss How They Built the Mental Wellness Network
Kelly O’Grady, chief host & correspondent for dot.LA speaks with Kendall Bird and Sage Grazer, co-founders of mental wellness network, Frame, which seeks to help people find a form of therapy and a therapist.
Techstars LA Class of 2020; What It's Like to Run an Accelerator During a Pandemic
On July 13, 2020 Techstars LA announced the ten startups that will make up its 2020 class, the first cohort to go remote due to COVID-19. Ben Bergman from dot.La, reports on how Techstars LA is evolving their programming to adjust to these challenging times.
Podcast: Biotech in LA & how founders not in health-tech should raise during COVID
In this episode of Fundraising Radio, BioscienceLA CEO David J. Whelan explains how founders working in bioscience and health tech can use this pandemic to their advantage during their fundraising and how other founders should adjust.
Kernel Raises $53M to make the Human Brain Easy to Read
Rachel Uranga of dot.LA reports that Kernel announced Thursday it's raised $53 million in a Series C round led by General Catalyst with other investors including Khosla Ventures, Eldridge, Manta Ray Ventures, Tiny Blue Dot and Kernel founder and CEO Bryan Johnson. Kernel is working to make the human brain, with all this inner workings, easy to read.
LA-based Xencor and Atreca Enter Strategic Collaboration
On July 8, 2020, Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, and Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response, announced via Business Wire that the companies have entered into a collaboration and license agreement to research, develop and commercialize T cell engaging bispecific antibodies as potential therapeutics in oncology.
Reports show LA bioscience sector continues to grow
Recent reporting by Howard Fine of Los Angeles Business Journal find that Los Angeles’ bioscience sector continues to grow and thrive. According to Fine’s report, “L.A.’s bioscience sector generated $44 billion in economic activity and nearly 196,000 jobs last year, increases of 4% and 2.5%, respectively, over 2018, according to an annual report released last month by an industry advocacy group.”
LA County's strategy to support local biotech startups
In a recent article reporter Rachel Uranga of dot.LA explores the efforts and investments made by the County of Los Angeles to grow the bioscience ecosystem in Los Angeles, including its recent $15 million matching loan to MarsBio, a venture fund focused on early stage bioscience startups.